Watch this event back to have your questions about HRD and genetics answered by Dr Alexandra Murray, Consultant Clinical Geneticist and Clinical Director at the University Hospital of Wales. DNA in our bodies is constantly being damaged and repairing itself. When your body is unable to repair breaks in DNA it’s called homologous recombination deficiency (HRD). If an ovarian tumour tests positive for HRD, it means that the cancer cells have a harder time repairing themselves. Some cancer treatments can help block this repairing process further. Find out about our upcoming digital support events and how to register to join us: https://targetovariancancer.org.uk/digital-events You can also find more information about our wellbeing and information events in the Ovarian Cancer Community, our kind, supportive group for everyone affected by ovarian cancer, including friends and family. Join today to find strength and community from people who understand what you’re going through: https://www.facebook.com/groups/ovariancancercommunity

Ovarian Cancer Awareness Month 2026 - Target Ovarian Cancer in Westminster
70 views

Understanding CA125 and NICE guideline updates on ovarian cancer testing | Dr Garth Funston Q&A
145 views

Ovarian Cancer Awareness Month 2026. Meet our heroes - Lindsay, Nicola, Reeta and Claire
124.8K views

Ovarian Cancer Awareness Month 2026 - Target Ovarian Cancer
305 views

Ask the Experts: ovarian cancer and recurrence
290 views

CA125 blood test for ovarian cancer
1.3K views